Clinical Trials
German regulator grants approval for Thermosome to begin THE001 trial
The trial’s primary endpoints are THE001’s safety and tolerability and determination of the maximum tolerated dose.
Ionis and AstraZeneca report additional positive topline data from a Phase III ATTRv-PN trial
Novartis Phase III Kisqali trial meets primary endpoint of iDFS
YS Biopharma reports positive data from Covid-19 vaccine trial
US FDA releases draft guidance for cancer clinical trials
Neurelis announces dosing of first two cohorts in CCM therapy trial
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
